| ABTS | 2,2′-azino-bis[3-ethylbenzthiazoline-6-sulphonic acid] |
| AChE | acetylcholinesterase |
| ANOVA | one-way analysis of variance |
| API | active pharmaceutical ingredient |
| ATCI | acetylthiocholine iodide |
| ATR | attenuated total reflectance |
| AUC | area under the curve |
| BBB | blood-brain barrier |
| BChE | butyrylcholinesterase |
| BCS | biopharmaceutics classification system |
| BTCI | butyrylthiocholine iodide |
| CNS | central nervous system |
| CUPRAC | cupric ion reducing antioxidant capacity |
| DAD | diode-array detector |
| DFT | Density functional theory |
| DTNB | 5,5′-dithio-bis-(2-nitrobenzoic) acid |
| FRAP | ferric reducing antioxidant power |
| FT-IR | Fourier-transform infrared spectroscopy |
| GIT | gastrointestinal tract |
| HP-β-CD | hydroxypropyl-β-cyclodextrin |
| HPLC | high-performance liquid chromatography |
| HPMC | hydroxypropylmethylcellulose |
| MD | molecular dynamics |
| NaHCO3 | sodium bicarbonate |
| NAR | naringenin |
| PAMPA | parallel artificial membrane permeability assay |
| RDF | radial distribution functions |
| TNB | 3-carboxy-4-nitrothiolate |
| WHO | World Health Organization |
| XRPD | X-ray powder diffraction |